SignalChem

SignalChem Lifesciences Corporation consists of two business units, a bioreaction unit, and a drug discovery unit. It focuses on the development of novel small-molecule kinase inhibitors for the treatment of human diseases to meet medical needs and produces kinase-related products to promote biomedical research and drug discovery efforts.